Align Technology, Inc.

Align Technology, Inc.

ALGN

Get informed when a big investor buys or sells

+ Follow
Market Cap$12.53B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Align Technology, Inc.Align Technology, Inc.29.1-10%2.80.3
$205.60

Target Price by Analysts

27.1% upsideAlign Technology Target Price DetailsTarget Price
$99.67

Current Fair Value

38.4% downside

Overvalued by 38.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$12.53 Billion
Enterprise Value$12.86 Billion
Dividend Yield$- (-)
Earnings per Share$5.66
Beta1.7
Outstanding Shares71,425,000

Return

Return on Equity10.36%ROE
Return on Assets6.81%
Return on Invested Capital13.32%

Valuation & Multiples

P/E Ratio29.07P/E Ratio
PEG138.68PEG
Price to Sales2.84Price to Sales
Price to Book Ratio2.79Price to Book Ratio
Enterprise Value to Revenue3.14
Enterprise Value to EBIT21.89
Enterprise Value to Net Income29
Total Debt to Enterprise0.11
Debt to Equity0.33Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
April 29, 2026
EPS Estimate
$2.26
Average shareholder expectation
Revenue Estimate
$1.02 B
Average shareholder expectation

Next Earnings Call

Expected Date
July 29, 2026
EPS Estimate
$2.64
Average shareholder expectation
Revenue Estimate
$1.06 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio1.2111 27.67%
Total Calls815,901 35.64%
Total Puts988,128 16.58%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %95.38% 3.98%
Total Invested$11.85B 14.42%
Investors Holding726 18.00%

ESG Score

No data

About Align Technology, Inc.

CEO: Thomas Prescott

Relevant Senate Committees

Joint Committee on Taxation

This committee provides the official analysis and 'scoring' for all tax legislation, directly influencing corporate tax structures and capital investment credits. Its technical expertise and reports directly shape the fiscal environment for companies like Align Technology.

Finance

This is a powerful committee controlling taxation, trade, and entitlement spending. Its decisions on corporate tax rates, tariffs on imported components, or healthcare entitlement policies (which can influence overall healthcare pricing) directly impact Align Technology's profitability and cost of goods.

Health, Education, Labor, and Pensions

This committee has direct oversight of the FDA, which regulates medical devices. Its decisions on device approvals, safety standards, and labeling requirements are paramount to Align Technology's ability to develop, market, and sell its products.

Judiciary

This committee directly oversees antitrust laws and intellectual property. For a medical device company like Align Technology, protecting patents and trade secrets is critical, and antitrust scrutiny could impact its market strategy or M&A activities.